Jeanny B. Aragon-Ching, M.D., F.A.C.P.

Title: Clinical Program Director of Genitourinary Cancers
Institution: INOVA Comprehensive Cancer and Research Institute
Address: 8505 Arlington Boulevard Suite 100, Fairfax, VA

Brief introduction

Jeanny Aragon-Ching, MD, FACP, is board-certified in Internal Medicine, Medical Oncology, and Hematology. She serves as the Clinical Program Director of Genitourinary Cancers at INOVA Comprehensive Cancer and Research Institute at Fairfax, Virginia, United States. Formerly affiliated with the George Washington University School of Medicine and Health Sciences in Washington, District of Columbia, she was a member of the Division of Hematology and Oncology and an Associate Professor of Medicine at the George Washington University School of Medicine & Health Sciences. Her research focus includes Genitourinary (GU) Oncology with special expertise in the clinical care of patients with prostate, bladder, kidney and testicular cancers.

Dr. Aragon-Ching served in varying capacities as an associate investigator and a principal investigator in different clinical trials of GU cancers and was a Fellow at the National Cancer Institute, Bethesda, Maryland, prior to coming to the George Washington University. She completed her residency training in Internal Medicine at the Albert Einstein Medical Center, Philadelphia, Pennsylvania, where she also served an additional year as Chief Resident. Her research interests include clinical trial design, biomarkers, and drug development in the field of prostate cancer.

Dr. Aragon-Ching was a co-recipient of the 2011 Elaine Snyder Cancer Research Award, was elected to Fellowship in the American College of Physicians since 2012, and has been named one of “Top Doctors” by Washingtonian magazine in 2014 and 2015. She has been active professionally and has chaired a general session in the 2014 American Society of Clinical Oncology (ASC0) Genitourinary Cancers Symposium, has given lectures at renowned symposiums such as the Best of ASCO and Society of Urologic Oncology. She has authored over 50 publications, including peer-reviewed articles, reviews, book chapters, commentaries, and invited editorials in high-impact journals such as the Clinical Cancer Research, Journal of Urology, the Lancet, and has served as a respected reviewer and on the Editorial board for various journals, including Asian Journal of Andrology.